Crohn's Disease Clinical Trials

2 recruiting

Frequently Asked Questions

Common questions about Crohn's Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Inflammatory Bowel Syndrome
American Laboratory Products Company220 enrolled3 locationsNCT06810518
Recruiting

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Traumatic Brain InjuryEhlers-Danlos SyndromePost-Acute COVID-19 Syndrome+41 more
Brain Inflammation Collaborative10,000 enrolled1 locationNCT04806620
Recruiting

Study on the Use of Traditional Chinese Medicine Diagnostic Tools to Assist in Identifying the Clinical Characteristics of Inflammatory Bowel Disease and Research on Metabolic Plastids of Tongue Coating

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)
China Medical University Hospital200 enrolled1 locationNCT07314151
Recruiting

Molecular Inflammation Board at the Center for Personalized Medicine

Psoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)+1 more
University Hospital Tuebingen3,000 enrolled1 locationNCT07132333
Recruiting

IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study

Intestinal UltrasoundPredictorCrohn's Disease+1 more
The Third Xiangya Hospital of Central South University50 enrolled1 locationNCT07034664
Recruiting

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Ulcerative ColitisInflammatory Bowel Disease (IBD)Crohn's Disease
Mercy Medical Center200 enrolled6 locationsNCT06750731
Recruiting
Phase 1

Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

Crohn's DiseasesActive Anal FistulaUpadacitinib
Sixth Affiliated Hospital, Sun Yat-sen University27 enrolled1 locationNCT06902987
Recruiting
Not Applicable

Standardized Fecal Microbiota Transplantation for Crohn's Diseases

Inflammatory Bowel DiseaseCrohn's Disease (CD)
The Second Hospital of Nanjing Medical University800 enrolled2 locationsNCT01793831